Search results
Results from the WOW.Com Content Network
A 2010 phase 2 trial found cetilistat significantly reduced weight and was better tolerated than orlistat. [ 34 ] SGLT2 inhibitors cause the loss of 60–100 grams (2.1–3.5 oz) glucose in the urine each day and are associated with a modest, sustained weight loss of 1.5–2 kilograms (3.3–4.4 lb) in people with type 2 diabetes.
In 2009, the US Food and Drug Administration (FDA) approved Onsolis (fentanyl buccal soluble film), a fentanyl drug in a new dosage form for cancer pain management in opioid-tolerant subjects. [150] It uses a medication delivery technology called BEMA (BioErodible MucoAdhesive), a small dissolvable polymer film containing various fentanyl doses ...
In 1959, phentermine first received approval from the US Food and Drug Administration (FDA) as an appetite suppressant. [43] Eventually a hydrochloride salt and a resin form became available. [43] Phentermine was marketed with fenfluramine or dexfenfluramine as a combination appetite suppressant and fat burning agent under the popular name fen ...
Zepbound was recently approved by the Food and Drug Administration (FDA) for weight loss in adults with overweight or obesity. The injectable medication is expected to be available by the end of ...
A new study compares the competing medications, and a clear winner emerges.
In a study testing a single drug delivering both the hormone and the molecules, mice who took it lost more weight than those taking existing medications. “The effect of GLP-1 combined with these ...
A fat substitute is a food product with the same functions, stability, physical, and chemical characteristics as regular fat, with fewer calories per gram than fat. They are utilized in the production of low fat and low calorie foods.
Years from now, we will look back in horror at the counterproductive ways we addressed the obesity epidemic and the barbaric ways we treated fat people—long after we knew there was a better path. I have never written a story where so many of my sources cried during interviews, where they shook with anger describing their interactions with ...